RIOCIGUAT

RIOCIGUAT was reported 32879 times

RIOCIGUAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY ANGIOPLASTY 23 0.8214
1 PULMONARY ENDARTERECTOMY 90 0.6164
2 PULMONARY ARTERY THERAPEUTIC PROCEDURE 20 0.5000
3 ENDARTERECTOMY 57 0.2545
4 BENDOPNOEA 42 0.1909
5 DIASTOLIC HYPOTENSION 32 0.1893
6 PULMONARY ARTERY OCCLUSION 16 0.1667
7 DIALYSIS HYPOTENSION 14 0.1414
8 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 24 0.1379
9 WALKING DISTANCE TEST ABNORMAL 53 0.1355
10 TRANSPLANT EVALUATION 67 0.1319
11 DEVICE WIRELESS COMMUNICATION ISSUE 32 0.1236
12 CATHETER SITE VESICLES 24 0.1231
13 PULMONARY ARTERIAL PRESSURE INCREASED 179 0.1098
14 CATHETER MANAGEMENT 98 0.1090
15 DEVICE MAINTENANCE ISSUE 64 0.1088
16 CATHETER SITE PRURITUS 90 0.1025
17 CARDIAC OUTPUT INCREASED 16 0.0936
18 CARDIAC FAILURE HIGH OUTPUT 22 0.0913
19 CATHETER SITE RASH 37 0.0819
20 THROMBECTOMY 26 0.0805
21 PULMONARY ARTERIAL HYPERTENSION 1130 0.0779
22 VASCULAR DEVICE OCCLUSION 26 0.0767
23 PULMONARY ARTERIAL PRESSURE ABNORMAL 22 0.0764
24 OXYGEN CONSUMPTION INCREASED 180 0.0753
25 CATHETER SITE IRRITATION 25 0.0751
26 INFUSION SITE INFECTION 171 0.0735
27 RIGHT VENTRICULAR FAILURE 498 0.0710
28 DIZZINESS EXERTIONAL 52 0.0684
29 PARACENTESIS 41 0.0667
30 CATHETER SITE ERYTHEMA 142 0.0663
31 CATHETER SITE DISCHARGE 72 0.0641
32 INFUSION SITE WARMTH 75 0.0612
33 INFUSION SITE ABSCESS 30 0.0595
34 OXYGEN SUPPLEMENTATION 44 0.0595
35 CATHETERISATION CARDIAC ABNORMAL 16 0.0593
36 DEPENDENCE ON OXYGEN THERAPY 29 0.0588
37 OXYGEN THERAPY 96 0.0584
38 INFUSION SITE DISCHARGE 102 0.0581
39 MINERAL SUPPLEMENTATION 26 0.0580
40 INFUSION SITE INDURATION 85 0.0573
41 INFUSION SITE INFLAMMATION 40 0.0567
42 CATHETER SITE SWELLING 51 0.0545
43 INFUSION SITE PAIN 687 0.0533
44 RIGHT VENTRICULAR ENLARGEMENT 17 0.0531
45 PULMONARY VENO-OCCLUSIVE DISEASE 37 0.0529
46 RIGHT VENTRICULAR DILATATION 30 0.0518
47 INFUSION SITE IRRITATION 66 0.0514
48 INFUSION SITE VESICLES 27 0.0513
49 BLOOD PRESSURE SYSTOLIC DECREASED 226 0.0496
50 DYSPNOEA AT REST 143 0.0493
51 CATHETERISATION CARDIAC 217 0.0489
52 INFUSION SITE HAEMORRHAGE 158 0.0480
53 INFUSION SITE CELLULITIS 25 0.0473
54 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 15 0.0473
55 VENTILATION PERFUSION MISMATCH 13 0.0463
56 INFUSION SITE ERYTHEMA 384 0.0455
57 PULMONARY HYPERTENSION 935 0.0448
58 DEVICE INFUSION ISSUE 111 0.0447
59 CATHETER SITE PAIN 116 0.0447
60 DYSPNOEA EXERTIONAL 1580 0.0419
61 LUNG TRANSPLANT 148 0.0418
62 ANGIOPLASTY 62 0.0415
63 INFUSION SITE DISCOMFORT 43 0.0415
64 DEVICE ALARM ISSUE 74 0.0407
65 HYPERVOLAEMIA 199 0.0402
66 CATHETER SITE EXTRAVASATION 16 0.0401
67 VASCULAR DEVICE INFECTION 180 0.0396
68 PAIN IN JAW 1092 0.0385
69 CATHETER SITE HAEMORRHAGE 96 0.0383
70 ABDOMINAL CAVITY DRAINAGE 16 0.0379
71 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 21 0.0374
72 SICKLE CELL DISEASE 17 0.0368
73 RIGHT VENTRICULAR DYSFUNCTION 40 0.0363
74 CHRONIC LEFT VENTRICULAR FAILURE 13 0.0361
75 INFUSION SITE SWELLING 227 0.0360
76 SICKLE CELL ANAEMIA 23 0.0357
77 FLUID RETENTION 1769 0.0347
78 CATHETER SITE RELATED REACTION 26 0.0347
79 INFUSION SITE RASH 47 0.0342
80 CATHETER SITE INFLAMMATION 19 0.0337
81 LUNG OPERATION 27 0.0322
82 BLOOD PRESSURE DIASTOLIC DECREASED 238 0.0322
83 BRAIN NATRIURETIC PEPTIDE INCREASED 99 0.0321
84 MEDICAL PROCEDURE 51 0.0306
85 INFUSION SITE PRURITUS 95 0.0301
86 JUGULAR VEIN DISTENSION 17 0.0300
87 FLUID OVERLOAD 436 0.0299
88 CENTRAL VENOUS CATHETER REMOVAL 14 0.0299
89 CENTRAL VENOUS CATHETERISATION 89 0.0295
90 DIZZINESS POSTURAL 286 0.0295
91 COR PULMONALE 28 0.0293
92 BIOPSY LIVER 12 0.0292
93 CARDIORENAL SYNDROME 16 0.0279
94 LOCALISED OEDEMA 128 0.0276
95 INFUSION SITE DISCOLOURATION 24 0.0273
96 TRANSFUSION 280 0.0267
97 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 37 0.0263
98 PACKED RED BLOOD CELL TRANSFUSION 34 0.0257
99 CHRONIC RESPIRATORY FAILURE 31 0.0257
100 INFUSION SITE REACTION 76 0.0254
101 ASPIRATION PLEURAL CAVITY 19 0.0247
102 INTRA-ABDOMINAL FLUID COLLECTION 44 0.0245
103 SCLERODERMA 89 0.0245
104 TRAUMATIC FRACTURE 18 0.0245
105 INFUSION SITE URTICARIA 16 0.0239
106 SYSTEMIC SCLERODERMA 17 0.0234
107 INFUSION SITE OEDEMA 19 0.0227
108 CATHETER PLACEMENT 42 0.0226
109 OXYGEN SATURATION DECREASED 1271 0.0226
110 NOCTURNAL DYSPNOEA 28 0.0219
111 FOOD REFUSAL 18 0.0206
112 RALES 116 0.0200
113 PULMONARY PAIN 58 0.0198
114 INFUSION SITE NODULE 19 0.0198
115 OEDEMA 1066 0.0196
116 CATHETER SITE INFECTION 74 0.0195
117 SEASONAL ALLERGY 276 0.0195
118 CARDIAC SEPTAL DEFECT 14 0.0195
119 OXYGEN SATURATION ABNORMAL 55 0.0194
120 HAEMOPTYSIS 540 0.0193
121 EMERGENCY CARE 58 0.0191
122 BLOOD PRESSURE MEASUREMENT 12 0.0187
123 CRITICAL ILLNESS 14 0.0179
124 INTENSIVE CARE 25 0.0176
125 DEVICE CONNECTION ISSUE 37 0.0175
126 DRUG DOSE TITRATION NOT PERFORMED 32 0.0175
127 CARDIAC ABLATION 31 0.0173
128 HYPOTENSION 3452 0.0172
129 DERMATITIS CONTACT 195 0.0171
130 CARDIAC OUTPUT DECREASED 15 0.0170
131 ARTERIOVENOUS MALFORMATION 15 0.0165
132 PULMONARY THROMBOSIS 180 0.0165
133 CARDIOVERSION 23 0.0165
134 PROCEDURAL HYPOTENSION 14 0.0165
135 THERAPY CHANGE 159 0.0162
136 CARBON DIOXIDE INCREASED 22 0.0161
137 ECHOCARDIOGRAM ABNORMAL 22 0.0157
138 REHABILITATION THERAPY 60 0.0155
139 EXERCISE TOLERANCE DECREASED 88 0.0153
140 HOSPITALISATION 2326 0.0151
141 OEDEMA PERIPHERAL 1802 0.0148
142 NASAL CONGESTION 849 0.0144
143 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 14 0.0139
144 INFUSION SITE MASS 15 0.0138
145 DEVICE POWER SOURCE ISSUE 40 0.0137
146 INJECTION SITE INFECTION 45 0.0137
147 DRUG TITRATION ERROR 35 0.0135
148 BLOOD PRESSURE DECREASED 894 0.0134
149 BLADDER CATHETERISATION 13 0.0134
150 PERICARDIAL EFFUSION 307 0.0133
151 HYPOXIA 467 0.0132
152 DEVICE RELATED INFECTION 200 0.0130
153 HAEMOGLOBIN INCREASED 59 0.0129
154 DEVICE RELATED SEPSIS 26 0.0129
155 LEFT VENTRICULAR FAILURE 44 0.0128
156 DYSPEPSIA 1252 0.0127
157 VASODILATATION 32 0.0127
158 LABILE BLOOD PRESSURE 15 0.0126
159 ACUTE RESPIRATORY FAILURE 243 0.0126
160 INFUSION SITE BRUISING 27 0.0125
161 COLONOSCOPY 27 0.0122
162 INTERNAL HAEMORRHAGE 140 0.0122
163 BREATH SOUNDS ABNORMAL 60 0.0122
164 EPISTAXIS 899 0.0120
165 CARDIAC FAILURE ACUTE 80 0.0120
166 BLOOD PRESSURE ABNORMAL 237 0.0119
167 MIDDLE EAR EFFUSION 25 0.0113
168 NASAL DRYNESS 71 0.0113
169 BLOOD ELECTROLYTES DECREASED 16 0.0113
170 PRESYNCOPE 272 0.0112
171 ASCITES 327 0.0111
172 BLOOD LOSS ANAEMIA 25 0.0110
173 ATRIAL FLUTTER 88 0.0110
174 CONCOMITANT DISEASE AGGRAVATED 68 0.0110
175 PERIPHERAL SWELLING 1670 0.0108
176 DISEASE COMPLICATION 49 0.0107
177 ORTHOPNOEA 34 0.0107
178 SYNCOPE 1061 0.0106
179 LOWER RESPIRATORY TRACT CONGESTION 18 0.0106
180 SINUS CONGESTION 142 0.0105
181 GENERALISED OEDEMA 129 0.0104
182 WEIGHT ABNORMAL 25 0.0104
183 DRUG TOLERANCE DECREASED 29 0.0103
184 DYSPNOEA 5794 0.0102
185 PRODUCTIVE COUGH 487 0.0102
186 DECREASED ACTIVITY 110 0.0102
187 DEVICE OCCLUSION 142 0.0101
188 DIALYSIS 142 0.0100
189 LIP INJURY 13 0.0099
190 CARDIAC FAILURE CHRONIC 42 0.0098
191 PURULENT DISCHARGE 42 0.0098
192 BLOOD POTASSIUM DECREASED 293 0.0097
193 PARANASAL SINUS HYPERSECRETION 37 0.0097
194 HAEMORRHOIDAL HAEMORRHAGE 47 0.0096
195 COMPLICATION ASSOCIATED WITH DEVICE 139 0.0096
196 MULTIPLE ALLERGIES 75 0.0096
197 PAINFUL RESPIRATION 23 0.0095
198 BLOOD IRON DECREASED 113 0.0095
199 WRONG DOSE 23 0.0095
200 MECHANICAL VENTILATION 18 0.0095
201 CARDIAC DISCOMFORT 19 0.0094
202 RESPIRATORY TRACT CONGESTION 148 0.0093
203 THERAPEUTIC PROCEDURE 13 0.0093
204 ENDOTRACHEAL INTUBATION 26 0.0093
205 FAECES SOFT 67 0.0092
206 GASTROOESOPHAGEAL REFLUX DISEASE 729 0.0090
207 HOSPICE CARE 89 0.0090
208 GASTRIC DILATATION 15 0.0090
209 IRON DEFICIENCY ANAEMIA 83 0.0090
210 OTORRHOEA 15 0.0086
211 THERAPY NON-RESPONDER 386 0.0086
212 HERNIA REPAIR 22 0.0085
213 RESPIRATION ABNORMAL 58 0.0084
214 MYOCARDIAL NECROSIS MARKER INCREASED 14 0.0083
215 SPUTUM DISCOLOURED 78 0.0082
216 RESPIRATORY TRACT INFECTION VIRAL 19 0.0082
217 WEIGHT FLUCTUATION 85 0.0081
218 EAR CONGESTION 22 0.0081
219 GOUT 144 0.0080
220 PULMONARY OEDEMA 359 0.0080
221 NASAL OBSTRUCTION 15 0.0080
222 ABDOMINAL DISTENSION 834 0.0080
223 THROMBOSIS IN DEVICE 26 0.0079
224 CARDIAC OPERATION 68 0.0079
225 PRODUCT ADMINISTRATION INTERRUPTED 62 0.0079
226 CARDIAC PACEMAKER INSERTION 47 0.0079
227 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 12 0.0078
228 CHOKING SENSATION 43 0.0078
229 TERMINAL STATE 52 0.0078
230 ABNORMAL LOSS OF WEIGHT 53 0.0078
231 RETCHING 164 0.0077
232 FACE INJURY 29 0.0076
233 PRODUCT SUPPLY ISSUE 54 0.0076
234 CHEST PAIN 1379 0.0074
235 PULMONARY CONGESTION 98 0.0074
236 LUNG DISORDER 364 0.0074
237 FLUSHING 752 0.0074
238 PANCREATIC CYST 14 0.0073
239 HEADACHE 4575 0.0073
240 SINUS PAIN 17 0.0073
241 FOOD POISONING 39 0.0073
242 DIZZINESS 3589 0.0072
243 SINUS DISORDER 139 0.0070
244 SMALL INTESTINAL OBSTRUCTION 86 0.0070
245 HYPOPNOEA 24 0.0069
246 PALPITATIONS 807 0.0069
247 PARANASAL SINUS DISCOMFORT 26 0.0069
248 HEART RATE ABNORMAL 38 0.0068
249 INVESTIGATION 21 0.0067
250 CONCOMITANT DISEASE PROGRESSION 13 0.0066
251 GASTRIC POLYPS 15 0.0066
252 HEAD INJURY 210 0.0066
253 EYE CONTUSION 14 0.0066
254 OCCULT BLOOD POSITIVE 13 0.0066
255 CARDIOMEGALY 81 0.0066
256 CARDIAC FAILURE 528 0.0066
257 UPPER RESPIRATORY TRACT CONGESTION 19 0.0066
258 GASTRIC INFECTION 25 0.0065
259 PULMONARY HAEMORRHAGE 51 0.0065
260 COUGH 1827 0.0065
261 CARDIAC FLUTTER 42 0.0065
262 SUFFOCATION FEELING 16 0.0064
263 EAR DISCOMFORT 66 0.0064
264 RHINOVIRUS INFECTION 25 0.0064
265 DISCOURAGEMENT 15 0.0064
266 SKIN ABRASION 30 0.0063
267 CHEST DISCOMFORT 648 0.0063
268 HEAD DISCOMFORT 112 0.0063
269 DEATH 5421 0.0063
270 BLOOD COUNT ABNORMAL 95 0.0063
271 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
272 HAEMATEMESIS 158 0.0062
273 ATRIAL TACHYCARDIA 13 0.0062
274 HAEMATOCRIT INCREASED 14 0.0061
275 SWELLING 575 0.0061
276 FACIAL BONES FRACTURE 22 0.0061
277 VIRAL UPPER RESPIRATORY TRACT INFECTION 29 0.0061
278 CARDIAC FAILURE CONGESTIVE 490 0.0061
279 HEART RATE INCREASED 604 0.0061
280 THROAT IRRITATION 272 0.0061
281 DEVICE FAILURE 92 0.0060
282 GASTROENTERITIS VIRAL 109 0.0060
283 GASTRIC DISORDER 203 0.0059
284 TRANSPLANT 14 0.0059
285 UPPER-AIRWAY COUGH SYNDROME 48 0.0058
286 INTERNATIONAL NORMALISED RATIO ABNORMAL 20 0.0058
287 CARDIAC DYSFUNCTION 21 0.0056
288 CLOSTRIDIUM DIFFICILE INFECTION 123 0.0056
289 EPIGASTRIC DISCOMFORT 22 0.0056
290 BLOOD POTASSIUM ABNORMAL 15 0.0056
291 POLYURIA 46 0.0056
292 DIARRHOEA 3574 0.0055
293 ABDOMINAL DISCOMFORT 927 0.0055
294 HAEMORRHAGE URINARY TRACT 14 0.0055
295 LIVER TRANSPLANT 20 0.0055
296 PNEUMONIA 1781 0.0055
297 BLOOD PRESSURE FLUCTUATION 131 0.0055
298 SINUS OPERATION 13 0.0055
299 INJECTION SITE DISCHARGE 29 0.0054
300 HAEMOGLOBIN DECREASED 552 0.0054
301 GASTROENTERITIS 78 0.0053
302 IRON DEFICIENCY 24 0.0053
303 LUNG OPACITY 14 0.0053
304 HYPERCAPNIA 16 0.0053
305 DEVICE DISLOCATION 230 0.0053
306 SUPRAVENTRICULAR TACHYCARDIA 50 0.0052
307 RESPIRATORY FAILURE 378 0.0052
308 ABDOMINAL RIGIDITY 14 0.0052
309 FEEDING DISORDER 104 0.0051
310 LOSS OF CONSCIOUSNESS 656 0.0051
311 DECREASED APPETITE 1188 0.0051
312 HAEMORRHAGIC DIATHESIS 18 0.0051
313 URINE OUTPUT DECREASED 44 0.0050
314 INCREASED TENDENCY TO BRUISE 46 0.0050
315 UNEVALUABLE EVENT 377 0.0050
316 JOINT SWELLING 596 0.0049
317 PLEURAL EFFUSION 300 0.0049
318 MOUTH HAEMORRHAGE 36 0.0049
319 CELLULITIS 247 0.0049
320 DEAFNESS UNILATERAL 27 0.0049
321 ANIMAL BITE 13 0.0049
322 BLOOD MAGNESIUM DECREASED 42 0.0049
323 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
324 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
325 NAUSEA 3819 0.0048
326 PRODUCT LEAKAGE 27 0.0048
327 SLUGGISHNESS 49 0.0048
328 GASTROINTESTINAL DISORDER 430 0.0048
329 RHINALGIA 13 0.0047
330 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
331 GALLBLADDER OPERATION 19 0.0047
332 GASTRIC HAEMORRHAGE 54 0.0047
333 OESOPHAGEAL ULCER 18 0.0047
334 GASTROINTESTINAL HAEMORRHAGE 386 0.0046
335 VOMITING 2147 0.0046
336 OESOPHAGEAL PAIN 18 0.0046
337 TRICUSPID VALVE INCOMPETENCE 36 0.0045
338 PAIN IN EXTREMITY 1332 0.0045
339 ERUCTATION 87 0.0045
340 CHEMOTHERAPY 17 0.0045
341 INTERNATIONAL NORMALISED RATIO INCREASED 128 0.0045
342 WEIGHT INCREASED 1004 0.0045
343 BLOOD BLISTER 14 0.0045
344 FAECES DISCOLOURED 97 0.0045
345 PROCEDURAL COMPLICATION 34 0.0044
346 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 231 0.0044
347 RESPIRATORY DISTRESS 122 0.0044
348 CONSTIPATION 960 0.0044
349 PNEUMONIA VIRAL 14 0.0044
350 SECRETION DISCHARGE 55 0.0044
351 RENAL DISORDER 204 0.0044
352 SINUS HEADACHE 26 0.0044
353 FLATULENCE 248 0.0044
354 FAECES HARD 17 0.0044
355 CREPITATIONS 13 0.0044
356 ORTHOSTATIC HYPOTENSION 76 0.0044
357 CARDIOPULMONARY FAILURE 17 0.0044
358 OLIGURIA 27 0.0043
359 CERVICAL VERTEBRAL FRACTURE 15 0.0043
360 NASOPHARYNGITIS 797 0.0043
361 OROPHARYNGEAL DISCOMFORT 39 0.0043
362 WEIGHT DECREASED 1202 0.0043
363 INTESTINAL OBSTRUCTION 162 0.0043
364 ANAL HAEMORRHAGE 12 0.0043
365 ABDOMINAL PAIN UPPER 877 0.0043
366 PERIORBITAL SWELLING 24 0.0042
367 RECTAL HAEMORRHAGE 182 0.0042
368 LIMB INJURY 115 0.0042
369 DIASTOLIC DYSFUNCTION 13 0.0042
370 ATRIAL FIBRILLATION 410 0.0042
371 DEVICE PLACEMENT ISSUE 15 0.0042
372 SICKLE CELL ANAEMIA WITH CRISIS 66 0.0042
373 DEHYDRATION 558 0.0042
374 NASAL DISCOMFORT 33 0.0042
375 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 14 0.0042
376 INFLUENZA 460 0.0041
377 AMMONIA INCREASED 21 0.0041
378 ANAEMIA 780 0.0041
379 HAEMATOCHEZIA 225 0.0041
380 MUSCULOSKELETAL CHEST PAIN 63 0.0041
381 FLANK PAIN 38 0.0040
382 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
383 CHOKING 79 0.0040
384 LYMPHOEDEMA 28 0.0040
385 CATARACT OPERATION 24 0.0040
386 AORTIC STENOSIS 14 0.0040
387 SENSITIVITY TO WEATHER CHANGE 21 0.0040
388 STENT PLACEMENT 32 0.0040
389 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
390 BEDRIDDEN 52 0.0040
391 HAEMORRHOIDS 77 0.0039
392 RHINORRHOEA 254 0.0039
393 FEELING ABNORMAL 941 0.0039
394 PERIPHERAL VENOUS DISEASE 16 0.0039
395 FEELING COLD 109 0.0039
396 INCORRECT DOSAGE ADMINISTERED 19 0.0039
397 FATIGUE 3021 0.0039
398 SKIN LACERATION 42 0.0039
399 MALAISE 1689 0.0038
400 CARDIOGENIC SHOCK 55 0.0038
401 BLOOD SODIUM DECREASED 72 0.0038
402 MUSCLE STRAIN 33 0.0038
403 ABNORMAL WEIGHT GAIN 47 0.0038
404 CARDIAC TAMPONADE 18 0.0038
405 UPPER RESPIRATORY TRACT INFECTION 175 0.0038
406 HEPATIC CIRRHOSIS 71 0.0038
407 PRODUCT AVAILABILITY ISSUE 86 0.0038
408 PRODUCT DOSE OMISSION 246 0.0038
409 GASTRITIS 99 0.0038
410 HEART RATE IRREGULAR 85 0.0038
411 GINGIVAL BLEEDING 51 0.0037
412 ASTHENIA 1401 0.0037
413 MELAENA 82 0.0037
414 LOCALISED INFECTION 90 0.0037
415 EAR DISORDER 17 0.0037
416 RESPIRATORY TRACT INFECTION 96 0.0037
417 FALL 1226 0.0037
418 VARICOSE VEIN 19 0.0037
419 ASPHYXIA 30 0.0037
420 NECK PAIN 205 0.0037
421 HAEMORRHAGE SUBCUTANEOUS 13 0.0037
422 THYROID MASS 14 0.0036
423 GALLBLADDER DISORDER 65 0.0036
424 HIATUS HERNIA 47 0.0036
425 BRONCHITIS 268 0.0036
426 OROPHARYNGEAL PAIN 335 0.0036
427 SLEEP APNOEA SYNDROME 69 0.0036
428 LARGE INTESTINE POLYP 25 0.0036
429 ULCER HAEMORRHAGE 24 0.0035
430 HAEMODYNAMIC INSTABILITY 27 0.0035
431 MUSCLE FATIGUE 15 0.0035
432 HAEMORRHAGE 370 0.0035
433 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
434 ABDOMINAL HERNIA 16 0.0035
435 CARDIAC VALVE DISEASE 20 0.0035
436 BLOOD DISORDER 28 0.0035
437 MYALGIA 591 0.0035
438 HYSTERECTOMY 30 0.0035
439 CONJUNCTIVAL HAEMORRHAGE 13 0.0034
440 THERAPY PARTIAL RESPONDER 53 0.0034
441 POOR QUALITY SLEEP 73 0.0034
442 HYPERSOMNIA 97 0.0034
443 ASPIRATION 37 0.0034
444 ILLNESS 348 0.0034
445 INFUSION SITE EXTRAVASATION 21 0.0034
446 CYANOSIS 53 0.0034
447 COMPRESSION FRACTURE 18 0.0034
448 HEPATOMEGALY 33 0.0034
449 PRODUCT PRESCRIBING ISSUE 73 0.0033
450 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
451 DRY THROAT 34 0.0033
452 SNEEZING 75 0.0033
453 ATRIAL SEPTAL DEFECT 28 0.0033
454 LIGAMENT SPRAIN 33 0.0033
455 HEART RATE DECREASED 117 0.0033
456 COVID-19 PNEUMONIA 39 0.0033
457 TOOTH EXTRACTION 41 0.0033
458 CARDIAC DISORDER 306 0.0033
459 DEVICE PHYSICAL PROPERTY ISSUE 25 0.0033
460 MIGRAINE 311 0.0033
461 THROMBOSIS 262 0.0033
462 EYE OPERATION 15 0.0033
463 DRUG INTOLERANCE 314 0.0032
464 MUSCULOSKELETAL PAIN 170 0.0032
465 IMPAIRED GASTRIC EMPTYING 44 0.0032
466 HAEMATOCRIT DECREASED 64 0.0032
467 WHEEZING 191 0.0032
468 DEVICE LEAKAGE 139 0.0032
469 OESOPHAGITIS 35 0.0032
470 FACE OEDEMA 54 0.0032
471 THERAPY CESSATION 164 0.0032
472 ACCIDENT 38 0.0032
473 NEURALGIA 77 0.0032
474 PNEUMONIA BACTERIAL 29 0.0032
475 DIVERTICULITIS 87 0.0031
476 VIRAL INFECTION 104 0.0031
477 ENDOCARDITIS 16 0.0031
478 GAIT INABILITY 104 0.0031
479 HYPERTHYROIDISM 45 0.0031
480 LETHARGY 178 0.0031
481 EAR PAIN 60 0.0031
482 SENSATION OF FOREIGN BODY 26 0.0031
483 BLOOD URINE PRESENT 58 0.0031
484 HERNIA 59 0.0030
485 EAR INFECTION 81 0.0030
486 SEPSIS 339 0.0030
487 TREATMENT NONCOMPLIANCE 166 0.0030
488 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
489 RENAL FUNCTION TEST ABNORMAL 14 0.0030
490 BACK PAIN 700 0.0030
491 POST PROCEDURAL HAEMORRHAGE 35 0.0030
492 ATELECTASIS 29 0.0030
493 OCULAR ICTERUS 13 0.0030
494 EYE HAEMORRHAGE 40 0.0030
495 DIARRHOEA HAEMORRHAGIC 28 0.0030
496 LIMB DISCOMFORT 92 0.0030
497 UPPER GASTROINTESTINAL HAEMORRHAGE 50 0.0030
498 EATING DISORDER 63 0.0030
499 BACTERAEMIA 35 0.0029
500 TACHYCARDIA 261 0.0029
501 SUBDURAL HAEMATOMA 42 0.0029
502 BLOOD TEST ABNORMAL 41 0.0029
503 ENERGY INCREASED 17 0.0029
504 CORONAVIRUS INFECTION 19 0.0029
505 POST PROCEDURAL COMPLICATION 55 0.0029
506 UNINTENTIONAL MEDICAL DEVICE REMOVAL 33 0.0028
507 BACK INJURY 31 0.0028
508 SYSTEMIC LUPUS ERYTHEMATOSUS 101 0.0028
509 MUSCLE TIGHTNESS 46 0.0028
510 PNEUMOTHORAX 45 0.0028
511 WRIST FRACTURE 34 0.0028
512 CONTUSION 273 0.0028
513 LUNG INFECTION 44 0.0028
514 URINARY TRACT INFECTION 483 0.0028
515 RIB FRACTURE 58 0.0028
516 ABDOMINAL TENDERNESS 14 0.0028
517 CHOLECYSTECTOMY 32 0.0028
518 FLUID INTAKE REDUCED 14 0.0028
519 SURGERY 164 0.0028
520 INGUINAL HERNIA 17 0.0028
521 SINUSITIS 286 0.0028
522 MUSCULOSKELETAL DISCOMFORT 48 0.0028
523 GENERAL PHYSICAL HEALTH DETERIORATION 322 0.0028
524 SWELLING FACE 181 0.0028
525 FREQUENT BOWEL MOVEMENTS 75 0.0028
526 MENTAL STATUS CHANGES 77 0.0028
527 TOOTHACHE 50 0.0028
528 HAEMATOMA 71 0.0027
529 UTERINE LEIOMYOMA 20 0.0027
530 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
531 HYPOVOLAEMIA 16 0.0027
532 COLD SWEAT 48 0.0027
533 CONCUSSION 21 0.0027
534 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
535 ARRHYTHMIA 128 0.0027
536 SCIATICA 43 0.0027
537 FAILURE TO THRIVE 14 0.0027
538 PHOTOPSIA 17 0.0027
539 HAND FRACTURE 19 0.0027
540 BACTERIAL INFECTION 50 0.0027
541 GASTROINTESTINAL INFECTION 24 0.0027
542 RESPIRATORY DISORDER 80 0.0027
543 ELECTROLYTE IMBALANCE 31 0.0027
544 ANAL INCONTINENCE 24 0.0027
545 INTENTIONAL DOSE OMISSION 76 0.0027
546 PULMONARY EMBOLISM 253 0.0027
547 ABDOMINAL PAIN 618 0.0027
548 TOOTH ABSCESS 27 0.0026
549 CHOLECYSTITIS ACUTE 15 0.0026
550 POLLAKIURIA 110 0.0026
551 GASTROINTESTINAL PAIN 29 0.0026
552 MUCOUS STOOLS 13 0.0026
553 JOINT INJURY 56 0.0026
554 LABORATORY TEST ABNORMAL 77 0.0026
555 POLYP 17 0.0026
556 TINNITUS 119 0.0026
557 ANKLE FRACTURE 40 0.0026
558 SKIN WARM 15 0.0026
559 LACERATION 24 0.0025
560 ASTHENOPIA 14 0.0025
561 RESTLESS LEGS SYNDROME 46 0.0025
562 CANDIDA INFECTION 42 0.0025
563 THYROID DISORDER 38 0.0025
564 HYPOPHAGIA 63 0.0025
565 BLOOD POTASSIUM INCREASED 40 0.0025
566 PALLOR 67 0.0025
567 DECUBITUS ULCER 20 0.0025
568 KIDNEY INFECTION 48 0.0024
569 SEPTIC SHOCK 106 0.0024
570 HIP FRACTURE 78 0.0024
571 TASTE DISORDER 49 0.0024
572 CONDITION AGGRAVATED 731 0.0024
573 FEELING OF BODY TEMPERATURE CHANGE 14 0.0024
574 PRODUCT DISTRIBUTION ISSUE 22 0.0024
575 CHILLS 276 0.0024
576 HEAVY MENSTRUAL BLEEDING 21 0.0023
577 ILEUS 29 0.0023
578 MALNUTRITION 26 0.0023
579 LIVER DISORDER 103 0.0023
580 SPLENOMEGALY 27 0.0023
581 MUSCLE SPASMS 421 0.0023
582 DYSPHONIA 134 0.0023
583 RENAL FAILURE 303 0.0023
584 THERAPY INTERRUPTED 163 0.0023
585 NERVE COMPRESSION 21 0.0023
586 SCRATCH 24 0.0023
587 RED BLOOD CELL COUNT DECREASED 65 0.0023
588 BLOOD UREA INCREASED 38 0.0023
589 FEELING HOT 139 0.0023
590 APPETITE DISORDER 15 0.0023
591 GASTRIC ULCER 43 0.0023
592 RESPIRATORY RATE INCREASED 20 0.0023
593 ENTEROCOLITIS 13 0.0022
594 PLATELET COUNT DECREASED 240 0.0022
595 STAPHYLOCOCCAL INFECTION 74 0.0022
596 FACIAL PAIN 20 0.0022
597 ARTHRALGIA 930 0.0022
598 INFLUENZA LIKE ILLNESS 184 0.0022
599 TROPONIN INCREASED 17 0.0022
600 RHINITIS 18 0.0022
601 UPPER LIMB FRACTURE 44 0.0022
602 EYE SWELLING 82 0.0022
603 HOT FLUSH 166 0.0022
604 SARS-COV-2 TEST POSITIVE 29 0.0022
605 SPINAL OPERATION 27 0.0022
606 PULMONARY FIBROSIS 42 0.0022
607 DRUG DOSE OMISSION 361 0.0022
608 EMPHYSEMA 22 0.0022
609 HAEMOGLOBIN ABNORMAL 14 0.0022
610 FULL BLOOD COUNT ABNORMAL 23 0.0022
611 SKIN ULCER 56 0.0022
612 RENAL IMPAIRMENT 182 0.0022
613 VERTIGO 132 0.0022
614 NERVOUSNESS 113 0.0022
615 INJECTION SITE INDURATION 28 0.0022
616 LACRIMATION INCREASED 65 0.0021
617 FEELING JITTERY 41 0.0021
618 COLON CANCER 32 0.0021
619 DEAFNESS 56 0.0021
620 PRODUCT PREPARATION ISSUE 14 0.0021
621 DEVICE USE ERROR 74 0.0021
622 PHARYNGITIS STREPTOCOCCAL 23 0.0021
623 PAIN 1300 0.0021
624 CIRCULATORY COLLAPSE 36 0.0021
625 PERIPHERAL COLDNESS 29 0.0021
626 SCAB 24 0.0021
627 FRUSTRATION TOLERANCE DECREASED 17 0.0021
628 HYPOKALAEMIA 97 0.0021
629 ADVERSE EVENT 192 0.0021
630 SUDDEN DEATH 22 0.0021
631 BLOOD URIC ACID INCREASED 12 0.0021
632 PRODUCT DOSE OMISSION ISSUE 609 0.0021
633 SWELLING OF EYELID 13 0.0021
634 IRRITABLE BOWEL SYNDROME 44 0.0021
635 GASTROINTESTINAL INFLAMMATION 16 0.0020
636 ADVERSE DRUG REACTION 183 0.0020
637 TEMPERATURE INTOLERANCE 21 0.0020
638 PULMONARY MASS 30 0.0020
639 DEFAECATION URGENCY 14 0.0020
640 RENAL PAIN 21 0.0020
641 BRAIN FOG 31 0.0020
642 PYREXIA 683 0.0020
643 TOOTH INFECTION 26 0.0020
644 DIVERTICULUM 14 0.0020
645 INSOMNIA 524 0.0020
646 PHOTOPHOBIA 37 0.0020
647 SKIN INFECTION 22 0.0020
648 OCULAR DISCOMFORT 22 0.0020
649 GAIT DISTURBANCE 375 0.0020
650 INFLAMMATION 101 0.0020
651 BALANCE DISORDER 169 0.0020
652 DISEASE PROGRESSION 231 0.0020
653 HYPOACUSIS 84 0.0019
654 ULCER 31 0.0019
655 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
656 NEPHROLITHIASIS 89 0.0019
657 GROIN PAIN 17 0.0019
658 PHARYNGITIS 24 0.0019
659 APPENDICITIS 18 0.0019
660 LUNG INFILTRATION 17 0.0019
661 MUSCULAR WEAKNESS 218 0.0019
662 COVID-19 336 0.0019
663 BLOOD CREATININE INCREASED 125 0.0019
664 FOOT FRACTURE 36 0.0019
665 INCONTINENCE 20 0.0019
666 ARTHROPOD BITE 14 0.0019
667 DEVICE ISSUE 169 0.0019
668 EXTRA DOSE ADMINISTERED 76 0.0019
669 DYSURIA 69 0.0019
670 MULTIPLE ORGAN DYSFUNCTION SYNDROME 53 0.0019
671 ROAD TRAFFIC ACCIDENT 78 0.0019
672 COAGULOPATHY 31 0.0019
673 UNRESPONSIVE TO STIMULI 48 0.0019
674 CYSTITIS 59 0.0019
675 RETINAL DETACHMENT 17 0.0018
676 CARDIAC MURMUR 16 0.0018
677 CHOLECYSTITIS 22 0.0018
678 SHOCK HAEMORRHAGIC 15 0.0018
679 PNEUMONIA ASPIRATION 46 0.0018
680 MENORRHAGIA 36 0.0018
681 BLOOD GLUCOSE DECREASED 88 0.0018
682 VITREOUS FLOATERS 18 0.0018
683 ACUTE KIDNEY INJURY 280 0.0018
684 INFECTION 262 0.0018
685 PELVIC FRACTURE 14 0.0018
686 MOOD ALTERED 49 0.0018
687 PRODUCT USE ISSUE 337 0.0018
688 SPINAL PAIN 21 0.0018
689 DEPRESSED MOOD 94 0.0018
690 DYSPHAGIA 168 0.0018
691 CHOLELITHIASIS 58 0.0018
692 BLOOD ALBUMIN DECREASED 14 0.0018
693 SOMNOLENCE 355 0.0018
694 SKIN DISCOLOURATION 81 0.0018
695 FACIAL PARALYSIS 15 0.0018
696 HELICOBACTER INFECTION 18 0.0017
697 DRY MOUTH 142 0.0017
698 VISION BLURRED 240 0.0017
699 ANURIA 15 0.0017
700 RASH PRURITIC 94 0.0017
701 LOWER LIMB FRACTURE 33 0.0017
702 ABNORMAL FAECES 14 0.0017
703 INTERSTITIAL LUNG DISEASE 82 0.0017
704 CYST 21 0.0017
705 AGEUSIA 42 0.0017
706 ANXIETY 478 0.0017
707 DYSSTASIA 49 0.0017
708 PANIC ATTACK 61 0.0017
709 BONE PAIN 98 0.0017
710 HAEMODIALYSIS 14 0.0017
711 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 80 0.0017
712 BACK DISORDER 27 0.0017
713 CEREBRAL HAEMORRHAGE 59 0.0016
714 APHONIA 23 0.0016
715 MEMORY IMPAIRMENT 226 0.0016
716 CARPAL TUNNEL SYNDROME 23 0.0016
717 FULL BLOOD COUNT DECREASED 33 0.0016
718 HIP ARTHROPLASTY 25 0.0016
719 DEVICE MALFUNCTION 114 0.0016
720 SHOCK 37 0.0016
721 NEPHROPATHY 15 0.0016
722 MIDDLE INSOMNIA 30 0.0016
723 ARTHRITIS 125 0.0016
724 MICTURITION URGENCY 18 0.0016
725 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 284 0.0016
726 CARDIAC ARREST 130 0.0016
727 WOUND INFECTION 17 0.0016
728 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
729 TOOTH FRACTURE 17 0.0015
730 WOUND 43 0.0015
731 ANGINA PECTORIS 44 0.0015
732 TENDERNESS 16 0.0015
733 CARDIO-RESPIRATORY ARREST 64 0.0015
734 MENTAL IMPAIRMENT 37 0.0015
735 PSEUDOMONAS INFECTION 13 0.0015
736 HERPES ZOSTER 87 0.0015
737 NEUROPATHY PERIPHERAL 144 0.0015
738 MACULAR DEGENERATION 18 0.0015
739 VAGINAL HAEMORRHAGE 65 0.0015
740 TREMOR 248 0.0015
741 INJECTION SITE IRRITATION 19 0.0015
742 INTENTIONAL PRODUCT USE ISSUE 130 0.0015
743 THROAT TIGHTNESS 40 0.0015
744 COLITIS 56 0.0015
745 MOBILITY DECREASED 106 0.0015
746 PNEUMONITIS 40 0.0015
747 ABDOMINAL PAIN LOWER 37 0.0015
748 LIVER FUNCTION TEST INCREASED 31 0.0014
749 EYE DISCHARGE 15 0.0014
750 AUTOIMMUNE DISORDER 14 0.0014
751 OSTEOMYELITIS 26 0.0014
752 PRODUCT ADMINISTRATION ERROR 29 0.0014
753 OCULAR HYPERAEMIA 68 0.0014
754 ERYTHEMA 294 0.0014
755 CATARACT 85 0.0014
756 KNEE OPERATION 14 0.0014
757 ACCIDENTAL OVERDOSE 52 0.0014
758 MUSCLE ATROPHY 18 0.0014
759 HYPOAESTHESIA 212 0.0014
760 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
761 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
762 SPEECH DISORDER 74 0.0014
763 BURNING SENSATION 99 0.0014
764 BLADDER DISORDER 14 0.0014
765 HAEMORRHAGE INTRACRANIAL 21 0.0014
766 THIRST 25 0.0014
767 HEPATIC ENCEPHALOPATHY 13 0.0014
768 DISORIENTATION 55 0.0014
769 DYSGEUSIA 103 0.0014
770 JOINT STIFFNESS 36 0.0014
771 BLOOD BILIRUBIN INCREASED 37 0.0014
772 ORAL CANDIDIASIS 18 0.0014
773 ADVERSE REACTION 18 0.0014
774 DISCOMFORT 82 0.0013
775 PETECHIAE 14 0.0013
776 QUALITY OF LIFE DECREASED 18 0.0013
777 URINARY RETENTION 44 0.0013
778 NOCTURIA 16 0.0013
779 LUNG NEOPLASM MALIGNANT 54 0.0013
780 INCREASED APPETITE 25 0.0013
781 RESPIRATORY ARREST 36 0.0013
782 ENCEPHALOPATHY 32 0.0013
783 OVARIAN CYST 13 0.0013
784 SPINAL FRACTURE 26 0.0013
785 ORAL DISCOMFORT 18 0.0013
786 ORAL PAIN 29 0.0013
787 HEPATIC FAILURE 39 0.0013
788 SLEEP DISORDER 91 0.0013
789 URINARY INCONTINENCE 38 0.0013
790 DEVICE BREAKAGE 52 0.0013
791 HYPERTENSION 271 0.0013
792 CONFUSIONAL STATE 206 0.0013
793 HYPERHIDROSIS 164 0.0013
794 PROCEDURAL PAIN 35 0.0013
795 BRONCHOSPASM 18 0.0013
796 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
797 LOWER RESPIRATORY TRACT INFECTION 57 0.0013
798 EYE DISORDER 41 0.0012
799 BLOOD CALCIUM DECREASED 14 0.0012
800 EYE INFECTION 14 0.0012
801 DEVICE ADHESION ISSUE 19 0.0012
802 MITRAL VALVE INCOMPETENCE 14 0.0012
803 BURSITIS 15 0.0012
804 NO THERAPEUTIC RESPONSE 15 0.0012
805 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
806 BREAST PAIN 13 0.0012
807 VISUAL IMPAIRMENT 151 0.0012
808 MASS 17 0.0012
809 SKIN HAEMORRHAGE 18 0.0012
810 BLOOD PRESSURE INCREASED 184 0.0012
811 EYE PRURITUS 40 0.0012
812 CONTRAINDICATED PRODUCT ADMINISTERED 36 0.0012
813 LYMPHADENOPATHY 42 0.0012
814 THINKING ABNORMAL 22 0.0012
815 HEPATIC FUNCTION ABNORMAL 44 0.0012
816 INSURANCE ISSUE 18 0.0012
817 TACHYPNOEA 16 0.0012
818 RASH GENERALISED 30 0.0012
819 PRURITUS GENERALISED 25 0.0012
820 NODULE 15 0.0011
821 FUNGAL INFECTION 38 0.0011
822 KNEE ARTHROPLASTY 24 0.0011
823 IMMUNE SYSTEM DISORDER 15 0.0011
824 PANCREATITIS 60 0.0011
825 HYPOAESTHESIA ORAL 17 0.0011
826 PARAESTHESIA 176 0.0011
827 EYELID OEDEMA 13 0.0011
828 HAEMATURIA 38 0.0011
829 NEOPLASM MALIGNANT 74 0.0011
830 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
831 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
832 LOCAL SWELLING 19 0.0011
833 PLATELET COUNT INCREASED 14 0.0011
834 DEMENTIA 30 0.0011
835 FIBROMYALGIA 26 0.0011
836 INCORRECT DOSE ADMINISTERED 242 0.0011
837 SKIN IRRITATION 48 0.0010
838 END STAGE RENAL DISEASE 19 0.0010
839 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
840 TOOTH DISORDER 23 0.0010
841 PRURITUS 397 0.0010
842 VENTRICULAR TACHYCARDIA 17 0.0010
843 BODY TEMPERATURE INCREASED 21 0.0010
844 DEVICE USE ISSUE 18 0.0010
845 RASH ERYTHEMATOUS 49 0.0010
846 BLISTER 57 0.0010
847 HYPERSENSITIVITY 188 0.0010
848 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
849 ASPARTATE AMINOTRANSFERASE INCREASED 53 0.0010
850 RASH 431 0.0010
851 CHROMATURIA 22 0.0010
852 CHRONIC KIDNEY DISEASE 74 0.0010
853 RASH MACULAR 34 0.0010
854 INJECTION SITE WARMTH 20 0.0010
855 DEPRESSION 220 0.0010
856 SEIZURE 111 0.0010
857 APHASIA 29 0.0010
858 MUSCULOSKELETAL DISORDER 18 0.0009
859 BRADYCARDIA 50 0.0009
860 FEMUR FRACTURE 29 0.0009
861 UNDERDOSE 68 0.0009
862 HYPONATRAEMIA 52 0.0009
863 PHOTOSENSITIVITY REACTION 15 0.0009
864 CRYING 33 0.0009
865 CARDIOVASCULAR DISORDER 23 0.0009
866 EYE PAIN 51 0.0009
867 DYSARTHRIA 34 0.0009
868 PARAESTHESIA ORAL 13 0.0009
869 PRODUCT USE COMPLAINT 14 0.0009
870 INJECTION SITE ERYTHEMA 110 0.0009
871 OBESITY 14 0.0009
872 ALANINE AMINOTRANSFERASE INCREASED 53 0.0009
873 ASTHMA 97 0.0009
874 HYPOGLYCAEMIA 41 0.0008
875 MUSCULOSKELETAL STIFFNESS 74 0.0008
876 SKIN DISORDER 28 0.0008
877 APPLICATION SITE PRURITUS 19 0.0008
878 DEEP VEIN THROMBOSIS 53 0.0008
879 AMNESIA 53 0.0008
880 BLOOD GLUCOSE ABNORMAL 15 0.0008
881 DERMATITIS 17 0.0008
882 INTENTIONAL PRODUCT MISUSE 71 0.0008
883 RASH PAPULAR 18 0.0008
884 COMA 38 0.0008
885 METASTASES TO LIVER 14 0.0008
886 FRACTURE 15 0.0008
887 INJECTION SITE RASH 24 0.0008
888 GLAUCOMA 15 0.0008
889 NIGHT SWEATS 25 0.0008
890 ILL-DEFINED DISORDER 47 0.0008
891 DIPLOPIA 20 0.0008
892 OFF LABEL USE 674 0.0008
893 PANCYTOPENIA 43 0.0008
894 ORAL HERPES 15 0.0008
895 RESTLESSNESS 28 0.0008
896 DYSKINESIA 31 0.0008
897 DIABETES MELLITUS 58 0.0008
898 HEPATIC STEATOSIS 14 0.0008
899 LIP SWELLING 25 0.0007
900 INJECTION SITE PRURITUS 50 0.0007
901 INJECTION SITE HAEMORRHAGE 59 0.0007
902 DRUG ERUPTION 13 0.0007
903 OSTEOARTHRITIS 31 0.0007
904 URTICARIA 121 0.0007
905 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
906 DELIRIUM 25 0.0007
907 HYPOTHYROIDISM 23 0.0007
908 IRRITABILITY 43 0.0007
909 HYPERKALAEMIA 25 0.0007
910 DISABILITY 14 0.0007
911 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
912 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
913 THROMBOCYTOPENIA 77 0.0007
914 ABASIA 17 0.0007
915 EMOTIONAL DISORDER 21 0.0007
916 INJECTION SITE SWELLING 52 0.0007
917 MENTAL DISORDER 29 0.0007
918 HALLUCINATION 50 0.0007
919 BLINDNESS 27 0.0007
920 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
921 MUSCLE TWITCHING 15 0.0007
922 MYOCARDIAL INFARCTION 113 0.0006
923 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
924 ACUTE MYOCARDIAL INFARCTION 19 0.0006
925 THERAPEUTIC RESPONSE DECREASED 39 0.0006
926 PLASMA CELL MYELOMA 25 0.0006
927 SWOLLEN TONGUE 20 0.0006
928 CEREBROVASCULAR ACCIDENT 108 0.0006
929 ALOPECIA 124 0.0006
930 PAIN OF SKIN 17 0.0006
931 DISTURBANCE IN ATTENTION 34 0.0006
932 HEPATIC CANCER 15 0.0006
933 LIVER FUNCTION TEST ABNORMAL 18 0.0006
934 ARTHROPATHY 34 0.0006
935 LIVER INJURY 15 0.0006
936 NERVOUS SYSTEM DISORDER 19 0.0006
937 DRY SKIN 81 0.0006
938 DRUG INTERACTION 95 0.0006
939 CORONARY ARTERY DISEASE 18 0.0006
940 METABOLIC ACIDOSIS 19 0.0006
941 INJECTION SITE PAIN 182 0.0006
942 GASTRIC CANCER 15 0.0006
943 APPLICATION SITE PAIN 13 0.0006
944 TRANSAMINASES INCREASED 13 0.0006
945 NEEDLE ISSUE 17 0.0006
946 OSTEOPOROSIS 24 0.0006
947 SKIN LESION 16 0.0006
948 APPLICATION SITE ERYTHEMA 15 0.0006
949 AGITATION 42 0.0006
950 DEVICE DIFFICULT TO USE 37 0.0006
951 HEPATIC ENZYME INCREASED 36 0.0005
952 C-REACTIVE PROTEIN INCREASED 19 0.0005
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 105 0.0005
954 VISUAL ACUITY REDUCED 17 0.0005
955 ANGIOEDEMA 22 0.0005
956 INJURY 34 0.0005
957 JAUNDICE 13 0.0005
958 RENAL INJURY 14 0.0005
959 BLOOD GLUCOSE INCREASED 88 0.0005
960 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
961 RHEUMATOID ARTHRITIS 52 0.0005
962 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
963 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
964 IMPAIRED HEALING 14 0.0004
965 BREAST CANCER 38 0.0004
966 COLITIS ULCERATIVE 18 0.0004
967 HYPERGLYCAEMIA 14 0.0004
968 ECZEMA 20 0.0004
969 SKIN BURNING SENSATION 27 0.0004
970 SKIN EXFOLIATION 31 0.0004
971 EYE IRRITATION 21 0.0004
972 PRODUCT USE IN UNAPPROVED INDICATION 90 0.0004
973 DRY EYE 18 0.0004
974 MEDICATION ERROR 20 0.0004
975 DRUG INEFFECTIVE 465 0.0004
976 COGNITIVE DISORDER 16 0.0003
977 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
978 OVERDOSE 66 0.0003
979 RENAL CANCER 13 0.0003
980 INJECTION SITE BRUISING 20 0.0003
981 ACNE 19 0.0003
982 ACCIDENTAL EXPOSURE TO PRODUCT 23 0.0002
983 BLADDER CANCER 13 0.0002
984 INJECTION SITE REACTION 15 0.0002
985 STOMATITIS 13 0.0002
986 SUICIDAL IDEATION 17 0.0002
987 PSORIASIS 23 0.0002
988 TREATMENT FAILURE 14 0.0002
989 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
990 TOXICITY TO VARIOUS AGENTS 19 0.0001
991 NEUTROPENIA 13 0.0001
992 NO ADVERSE EVENT 16 0.0001